ZGNX Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2022-03-07 | BREITMEYER JAMES B | director | 0 | U-Tender | D | 1,250 | 26.00 | 32,500.00 |
| 2022-03-07 | BREITMEYER JAMES B | director | 0 | D-Return | D | 9,375 | 24.56 | 230,250.00 |
| 2022-03-07 | BREITMEYER JAMES B | director | 0 | D-Return | D | 6,250 | 15.52 | 97,000.00 |
| 2022-03-07 | BREITMEYER JAMES B | director | 0 | D-Return | D | 9,000 | 12.80 | 115,200.00 |
| 2022-03-07 | BREITMEYER JAMES B | director | 0 | D-Return | D | 10,000 | 8.99 | 89,900.00 |
| 2022-03-07 | BREITMEYER JAMES B | director | 0 | D-Return | D | 20,000 | 12.75 | 255,000.00 |
| 2022-03-07 | BREITMEYER JAMES B | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | Stutts Mary E. | director | 0 | D-Return | D | 20,000 | 22.82 | 456,400.00 |
| 2022-03-07 | Stutts Mary E. | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | BOCK LOUIS C | director | 0 | D-Return | D | 9,000 | 12.80 | 115,200.00 |
| 2022-03-07 | BOCK LOUIS C | director | 0 | D-Return | D | 20,000 | 8.99 | 179,800.00 |
| 2022-03-07 | BOCK LOUIS C | director | 0 | D-Return | D | 20,000 | 12.75 | 255,000.00 |
| 2022-03-07 | BOCK LOUIS C | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | TANNENBAUM RENEE P | director | 0 | U-Tender | D | 32,567 | 26.00 | 846,742.00 |
| 2022-03-07 | TANNENBAUM RENEE P | director | 0 | D-Return | D | 3,000 | 12.80 | 38,400.00 |
| 2022-03-07 | TANNENBAUM RENEE P | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | Farfel Gail M | officer: See Remarks | 0 | U-Tender | D | 16,606 | 26.00 | 431,756.00 |
| 2022-03-07 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 30,289 | 13.96 | 422,834.00 |
| 2022-03-07 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 14,250 | 13.32 | 189,810.00 |
| 2022-03-07 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 45,000 | 10.35 | 465,750.00 |
| 2022-03-07 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 52,500 | 10.20 | 535,500.00 |
| 2022-03-07 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 35,000 | 27.36 | 957,600.00 |
| 2022-03-07 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 30,000 | 18.76 | 562,800.00 |
| 2022-03-07 | Farfel Gail M | officer: See Remarks | 0 | D-Return | D | 40,187 | 0.00 | 0.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | U-Tender | D | 25,022 | 26.00 | 650,572.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 53,125 | 24.16 | 1,283,500.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 8,125 | 16.64 | 135,200.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 28,125 | 10.64 | 299,250.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 28,500 | 13.32 | 379,620.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 60,000 | 10.35 | 621,000.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 60,000 | 10.20 | 612,000.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 39,000 | 27.36 | 1,067,040.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 30,000 | 18.76 | 562,800.00 |
| 2022-03-07 | Galer Bradley S. | officer: EVP & Chief Medical Officer | 0 | D-Return | D | 45,499 | 0.00 | 0.00 |
| 2022-03-07 | Loewy Caroline M | director | 0 | D-Return | D | 20,000 | 22.82 | 456,400.00 |
| 2022-03-07 | Loewy Caroline M | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | GARNER CAM L | director | 0 | U-Tender | D | 40,843 | 26.00 | 1,061,918.00 |
| 2022-03-07 | GARNER CAM L | director | 0 | D-Return | D | 20,000 | 8.99 | 179,800.00 |
| 2022-03-07 | GARNER CAM L | director | 0 | D-Return | D | 20,000 | 12.75 | 255,000.00 |
| 2022-03-07 | GARNER CAM L | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | U-Tender | D | 92,806 | 26.00 | 2,412,956.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 87,499 | 15.04 | 1,315,985.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 69,373 | 15.92 | 1,104,418.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 43,749 | 24.56 | 1,074,475.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 26,583 | 10.64 | 282,843.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 93,750 | 11.04 | 1,035,000.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 90,767 | 10.35 | 939,438.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 85,937 | 10.20 | 876,557.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 165,000 | 27.36 | 4,514,400.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 93,335 | 18.76 | 1,750,965.00 |
| 2022-03-07 | FARR STEPHEN J | director, officer: President & CEO | 0 | D-Return | D | 128,955 | 0.00 | 0.00 |
| 2022-03-07 | Waynick Denelle J | director | 0 | U-Tender | D | 584 | 26.00 | 15,184.00 |
| 2022-03-07 | Waynick Denelle J | director | 0 | D-Return | D | 20,000 | 22.82 | 456,400.00 |
| 2022-03-07 | Waynick Denelle J | director | 0 | D-Return | D | 22,000 | 17.83 | 392,260.00 |
| 2021-11-29 | TANNENBAUM RENEE P | director | 32,567 | S-Sale | D | 5,305 | 11.72 | 62,175.00 |
| 2021-08-10 | GARNER CAM L | director | 41,000 | P-Purchase | A | 10,000 | 14.83 | 148,298.00 |
| 2021-08-09 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 5,000 | A-Award | A | 5,000 | 0.00 | 0.00 |
| 2021-06-01 | TANNENBAUM RENEE P | director | 37,872 | P-Purchase | A | 5,000 | 17.05 | 85,247.00 |
| 2021-06-01 | Waynick Denelle J | director | 584 | P-Purchase | A | 584 | 17.07 | 9,969.00 |
| 2021-05-27 | BREITMEYER JAMES B | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | Waynick Denelle J | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | GARNER CAM L | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | BOCK LOUIS C | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | Loewy Caroline M | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | Stutts Mary E. | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-27 | TANNENBAUM RENEE P | director | 22,000 | A-Award | A | 22,000 | 17.83 | 392,260.00 |
| 2021-05-10 | GARNER CAM L | director | 31,000 | P-Purchase | A | 15,000 | 19.03 | 285,496.00 |
| 2021-03-26 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 30,000 | A-Award | A | 30,000 | 18.76 | 562,800.00 |
| 2021-03-26 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2021-03-26 | FARR STEPHEN J | director, officer: President and CEO | 93,335 | A-Award | A | 93,335 | 18.76 | 1,750,965.00 |
| 2021-03-26 | FARR STEPHEN J | director, officer: President and CEO | 46,665 | A-Award | A | 46,665 | 0.00 | 0.00 |
| 2021-03-26 | Farfel Gail M | officer: EVP/Chief Development Officer | 30,000 | A-Award | A | 30,000 | 18.76 | 562,800.00 |
| 2021-03-26 | Farfel Gail M | officer: EVP/Chief Development Officer | 15,000 | A-Award | A | 15,000 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 22,258 | M-Exempt | A | 1,625 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 21,803 | F-InKind | D | 455 | 20.70 | 9,418.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 21,202 | M-Exempt | A | 2,031 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 20,633 | F-InKind | D | 569 | 20.70 | 11,778.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 19,609 | M-Exempt | A | 1,562 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 19,171 | F-InKind | D | 438 | 20.70 | 9,067.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 4,875 | M-Exempt | D | 1,625 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 4,062 | M-Exempt | D | 2,031 | 0.00 | 0.00 |
| 2021-03-15 | Galer Bradley S. | officer: EVP/Chief Medical Officer | 1,562 | M-Exempt | D | 1,562 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 93,212 | M-Exempt | A | 6,875 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 90,834 | F-InKind | D | 2,378 | 20.70 | 49,225.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 88,066 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 86,337 | F-InKind | D | 1,729 | 20.70 | 35,790.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 84,795 | M-Exempt | A | 5,000 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 83,066 | F-InKind | D | 1,729 | 20.70 | 35,790.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 20,625 | M-Exempt | D | 6,875 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 15,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
| 2021-03-15 | FARR STEPHEN J | director, officer: President and CEO | 5,000 | M-Exempt | D | 5,000 | 0.00 | 0.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 15,318 | M-Exempt | A | 1,500 | 0.00 | 0.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 14,776 | F-InKind | D | 542 | 20.70 | 11,219.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 14,553 | M-Exempt | A | 2,031 | 0.00 | 0.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 13,818 | F-InKind | D | 735 | 20.70 | 15,214.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 13,109 | M-Exempt | A | 1,625 | 0.00 | 0.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 12,522 | F-InKind | D | 587 | 20.70 | 12,151.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 4,500 | M-Exempt | D | 1,500 | 0.00 | 0.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 4,062 | M-Exempt | D | 2,031 | 0.00 | 0.00 |
| 2021-03-15 | Farfel Gail M | officer: EVP/Chief Development Officer | 1,625 | M-Exempt | D | 1,625 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
